Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis
Angelo Sangiovanni(Ospedale Maggiore), Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Edoardo G. Giannini(Ospedale Policlinico San Martino), Riccardo Gattai(University of Pisa), Guglielmo Borgia(University of Naples Federico II), Anna Ludovica Fracanzani(University of Milan), Francesco Paolo Russo(University of Padua), Matteo Brunacci(University of Genoa), Gaia Pellegatta(Humanitas University), S. Maimone(University of Messina), Elia Biganzoli(Zimmer Biomet (Netherlands)), Luca Valenti(University of Milan), Roberto Filomia(University of Messina), Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), M. Barone(University of Bari Aldo Moro), Laura Forzenigo(University of Milan), Erica Villa(University of Modena and Reggio Emilia), Giovanni Raimondo(University of Messina), N. Terreni(Ospedale Valduce), Maurizia Rossana Brunetto(University of Pisa), Luca Marzi(Azienda Ospedaliero-Universitaria di Modena), Filippo Oliveri(University of Pisa), Martina Gambato(University of Padua), Maria Grazia Rumi(University of Milan), L Belli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Elisabetta Parente(University of Bari Aldo Moro), Ilaria Serio(University of Bologna), Massimo Colombo(IRCCS Humanitas Research Hospital), Eleonora Alimenti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 57
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789